Supplementary Materials for “Longitudinal Interferon-γ Release Assay Changes in Psoriasis Treated With Interleukin Inhibitors: A Single-Center Real-World Cohort Study in China”
Description
Supplementary materials accompanying the Brief Report entitled “Longitudinal Interferon-γ Release Assay Changes in Psoriasis Treated With Interleukin Inhibitors: A Single-Center Real-World Cohort Study in China,” accepted for publication in the Journal of the American Academy of Dermatology. The supplementary materials include Supplementary Tables S1–S3. Supplementary Table S1 presents baseline and treatment characteristics of the baseline T-SPOT-tested cohort by longitudinal T-SPOT.TB data availability. Supplementary Table S2 presents follow-up duration in the baseline-only cohort without repeat T-SPOT.TB testing. Supplementary Table S3 presents clinical characteristics of biologic non-switchers with negative-to-positive T-SPOT.TB conversion. All supplementary data are anonymized and deidentified, and no directly identifiable patient information is included.
Files
Institutions
- Chongqing Medical UniversityChongqing, Chongqing